Patrick Soon - Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner at ImmunityBio, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner
Stock Symbol
IBRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Patrick Soon since 11/4/2023

Holdings reported by Patrick Soon for ImmunityBio, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 32.6M $164M $5.02 Sep 11, 2023 Indirect
Common Stock 29.5M $148M $5.02 Sep 11, 2023 Direct
Restricted Stock Units 343K $1.39M $4.04 Feb 22, 2024 Direct Common Stock
Stock Option (right to buy) 1.19M Feb 22, 2024 Direct Common Stock
Amended and Restated Convertible Promissory Note $0 Sep 11, 2023 Indirect Common Stock
Amended and Restated Promissory Note $380M Dec 29, 2023 Indirect Common Stock
Convertible Promissory Note $30M Dec 29, 2023 Indirect Common Stock
Second Amended and Restated Convertible Promissory Note $0 Sep 11, 2023 Indirect Common Stock

Transactions reported by Patrick Soon for ImmunityBio, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.